| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |